1.1. De Groen PC, Gores GJ, LaRusso NF et al. Biliary tract cancers. NEJM 1999; 341 (18): 1368-78.2.2. Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol 2009; 15 (34): 4240-62.3.3. Patel T. Cholangiocarcinoma. Nat Cli. Pract Gastroenterol Hepatol 2006; 3: 33-42.4.4. Kuang D, Wang G. Hilar cholangiocarcinoma: Pathology and tumor biology. Front Med China 2010; 4: 371-7.5.5. Klatskin G. Adenocarcinoma of the hepatic ducts at its bifurcation within the porta hepatis. Am J Med 1965; 38: 241-56.6.6. Somer L, Andrejić B, Milošević P. Origin and pathological characteristics of Klatskin tumor: a case report and literature review. Pol J Pathol 2012; 63 (1): 65-70.7.7. Bismuth H, Corlette MB. Intrahepatic cholangioenteric anastomosis in carcinoma of the hilus of the liver. Surg Gynecol Obset 1975; 140: (170-8).8.8. Вишневский В.А., Тарасюк Т.И. Диагностика и хирургическое лечение рака проксимальных отделов внепеченочных желчных протоков (опухоль Клатскина). Практ. онкология. 2004; 5 (2): 126-34.9.9. Rang HP, Dale MM, Ritter JM, Flower RJ. Rang and Dale\'s Pharmacology. Elsevier Churchill Livingstone 2007.10.10. Tsuzuki T, Ogata Y, Lida S et al. Carcinoma of the bifurcation of the hepatic ductus. Arch Surg 1987; 205 (2): 111-8.11.11. Ouchi K, Matsuno S, Sato T. Long-term survival in carcinoma of biliary tract. Arch Surg 2007; 124: 248-52.12.12. Dawson JL, Heaton ND. Carcinoma of the biliary tree and gallbladder. Surgery Inter Edit 2006; 17: 84-8.13.13. Bamrungphon W, Prempracha N, Bunchu N et al. A new mucin antibody/enzyme-linked lectin-sandwich assay of serum MUC5AC mucin for the diagnosis of cholangiocarcinoma. Cancer Lett 2007; 247: 301-8.14.14. Кунцевич Г.И. Ультразвуковая диагностика в абдоминальной и сосудистой хирургии. Минск, 1999.15.15. Slattery JM, Sahani DV. What is the current state-of-the-art imaging for detection and staging of cholangiocarcinoma? Oncologist 2006; 11: 913-22.16.16. Hann LE, Getrajdman GI, Brown KT et al. Hepatic lobar atrophy: association with ipsilateral portal vein obstruction. AJR Am J Roentgenol 1996; 167: 1017-21.17.17. Lee HY, Kim SH, Lee JM et al. Preoperative assessment of resectability of hepatic hilar cholangiocarcinoma: combined CT and cholangiography with revised criteria. Radiology 2006; 239: 113-21.18.18. Romagnuolo J, Bardou M, Rahme E et al. Magnetic resonance cholangiopancreatography: a meta-analysis of test performance in suspected biliary disease. Ann Intern Med 2003; 139: 547-57.19.19. Chen CY, Shiesh SC, Tsao HC, Lin XZ. The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma - the influence of sampling time and hepatolithiasis. Hepatogastroenterology 2002; 49: 616-20.20.20. Hochwald SN, Burke EC, Jarnagin WR et al. Association of preoperative biliary stenting with increased postoperative infectious complications in proximal cholangiocarcinoma. Arch Surg 1999; 134: 261-6.21.21. NCCN Clinical Practice Guidelines in Oncology: Hepatobiliary Cancers. National Comprehensive Cancer Network 2011; 1 (1).22.22. Федоров В.Д., Вишневский В.А., Кубышкин В.А. и др. Хирургическое лечение рака общего печеночного протока. Кремл. мед. 2000; 2: 13-6.23.23. Su CH, Tsay SH, Wu CC et al. Factors influencing postoperative morbidity, mortality, and survival after resection for hilar cholangiocarcinoma. Ann Surg 1996; 223: 384-94.24.24. Mihalache F, Tantau M, Diaconu B et al. M. Survival and quality of life of cholangiocarcinoma patients: a prospective study over a 4 year period. J Gastrointestin Liver Dis 2010; 9: 285-90.25.25. Todoroki T, Kawamoto T, Koike N et al. Radical resection of hilar bile duct carcinoma and predictors of survival. Br J Surg 2000; 87: 306-13.26.26. Thongprasert S. The role of chemotherapy in cholangiocarcinoma. Ann Oncol 2005; 16 (Suppl. 2): 93-6.27.27. Ustundag Y, Bayraktar Y. Cholangiocarcinoma: a compact review of the literature. World J Gastroenterol 2008; 14 (42): 6458-66.28.28. Ortner MA. Photodynamic therapy in cholangiocarcinomas. Best Pract Res Clin Gastroenterol 2004; 18: 147-54.29.29. Tomizawa Y, Tian J. Photodynamic therapy for unresectable cholangiocarcinoma. Dig Dis Sci 2012; 57 (2): 274-83.30.30. Lau SH, Lau WY. Current therapy of hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 2012; 11 (1): 12-7.